This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEGAB071_L.jpg
The new company, to be called PeptiAID Inc, will research and develop peptide therapeutics for the current SARS-CoV-2 virus and potential future coronavirus outbreaks, the companies said in a release.
The joint venture also includes Takenaka Corp and Kishida Chemical Co.
